These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35837300)

  • 1. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Xia J; Jin G; Hua Q; Cui S; Li J
    Front Endocrinol (Lausanne); 2022; 13():917304. PubMed ID: 35837300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Mantovani A; Taverna A; Cappelli D; Beatrice G; Csermely A; Sani E; Byrne CD; Targher G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristic analysis of patients with type 2 diabetes mellitus combined with advanced stage chronic liver disease: a community population-based cross-sectional study in Heping District, Shenyang City (CHESS-LN 2101)].
    Lyu C; Fu WL; Gu Y; Wang LS; Wang XM; Liu X; Qian JM; Tao Z; Chen Y; Liu C; He RL; Guan X; Wang Y; Wang Y; Qi XL
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1194-1200. PubMed ID: 36891697
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function.
    Zhang Y; Li J; Liu H
    BMC Endocr Disord; 2022 May; 22(1):144. PubMed ID: 35641932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease.
    Xia J; Li J; Jin G; Yao D; Hua Q
    Diabetes Metab Syndr Obes; 2022; 15():1749-1759. PubMed ID: 35706476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
    Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
    J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
    Ji SS; Jiang HD; Jiang JC; Li J; Lin ST; Chen B; Xu SH
    Clin Chim Acta; 2019 Feb; 489():75-82. PubMed ID: 30471249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study.
    Leite NC; Villela-Nogueira CA; Ferreira MT; Cardoso CR; Salles GF
    Liver Int; 2016 Jul; 36(7):977-85. PubMed ID: 26509555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts.
    Kim J; Lee M; Kim SY; Kim JH; Nam JS; Chun SW; Park SE; Kim KJ; Lee YH; Nam JY; Kang ES
    Endocrinol Metab (Seoul); 2021 Aug; 36(4):823-834. PubMed ID: 34474517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients.
    Zhang Y; Li J; Ni Y; Wang Y; Liu H
    BMC Endocr Disord; 2021 May; 21(1):100. PubMed ID: 34006273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
    Zhou YJ; Ye FZ; Li YY; Pan XY; Chen YX; Wu XX; Xiong JJ; Liu WY; Xu SH; Chen YP; Zheng MH
    United European Gastroenterol J; 2019 Oct; 7(8):1124-1134. PubMed ID: 31662869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus.
    Duan W; Shi R; Yang F; Zhou Z; Wang L; Huang Z; Zang S
    Cardiovasc Diabetol; 2023 Oct; 22(1):297. PubMed ID: 37904173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
    Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
    Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Advanced Liver Fibrosis Among Patients With Type 2 Diabetes Mellitus: A Single-Centre Experience in Penang, Malaysia.
    Lee XH; Nor LM; Ang CS; Yeow TP; Lim SL
    J ASEAN Fed Endocr Soc; 2023; 38(1):52-61. PubMed ID: 37252406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.